바카라 카드카운팅 Biologics to exhibit at BIO USA 2025, marking 13 years of participation with a ‘dedicated booth’

[by Yu, Suin] 바카라 카드카운팅 Biologics announced on June 9 that it will participate in the '2025 BIO International Convention (BIO USA),' the world's largest exhibition in the biotechnology and pharmaceutical industry.

바카라 카드카운팅 USA is an event organized by the 바카라 카드카운팅technology Innovation Organization (바카라 카드카운팅) in the U.S., held annually in June across major 바카라 카드카운팅technology clusters in the country. The event is recognized as a key venue for international networking, where professionals from the 바카라 카드카운팅tech and pharmaceutical industries convene to explore potential partnerships.

This year's event will take place over four days, from June 16 to 19 (local time), at the Boston Convention & Exhib바카라 카드카운팅ion Center in Massachusetts, USA. Themed 'The World Can't Wa바카라 카드카운팅,' the convention is expected to attract over 20,000 industry professionals from around the world.

Since its establishment in 2011, 바카라 카드카운팅 Biologics has consistently participated in the event for 13 consecutive years, making it the sole Korean company to operate a 'single booth' throughout this period and highlighting its strong global order competitiveness. At this year’s event, the company will establish a 167 m2 booth at the entrance of the exhibition hall, an area with the highest foot traffic, to attract the attention of attendees.

Notably, to highlight the company's expanding contract development and manufacturing (CDMO) capabilities and new facilities and services, 바카라 카드카운팅 Biologics will showcase advanced features such as an LED wall and interactive touch screens. These installations aim to dynamically present various content and reinforce the brand’s image of future innovation by emphasizing the application of digital technology, a topic of significant interest in the biotechnology and pharmaceutical industries today.

The booth will introduce 바카라 카드카운팅 Biologics’ recent advancements and its vision to become a ‘global top-tier CDMO.’ Highlights include the world’s highest biopharmaceutical production capacity (CAPA) of 784,000 liters, achieved with the recent launch of Plant 5, along with capabilities in the development and production of multi-specific antibodies to quickly meet evolving customer needs. The booth will also present the expanded CDMO portfolio, which now includes a new antibody-drug conjugate (ADC) service introduced this year, and the company’s digital transformation (DT) initiatives, such as AI-based operations. Through these efforts, 바카라 카드카운팅 Biologics aims to promote its competitive strengths and actively seek collaborations in various fields.

Add바카라 카드카운팅ionally, promotional banners will be strategically placed in key areas of the exhib바카라 카드카운팅ion venue, like the sky bridge visible from the entrance and the stairs leading to the main event hall, ensuring visibil바카라 카드카운팅y to event participants from virtually any location. Through diverse content and these strategic placements, the company plans to expand 바카라 카드카운팅s contact points w바카라 카드카운팅h existing global customers while attracting new clients. This effort seeks to increase brand awareness and market share in the global CDMO market, particularly in the Un바카라 카드카운팅ed States.